Induced Pluripotent Stem (iPS) Cells

Organoid Culture Using Skin Keratinocytes Derived from Human Induced Pluripotent Stem Cells. - Pluripotent Stem Cell Differentiation Toward Functional Basal Stratified Epithelial Cells. - Serum-Free Production of Three-Dimensional Hepatospheres from Pluripotent Stem Cells. - The Differentiation of Human Induced Pluripotent Stem Cells into Podocytes In Vitro. - A Method for Encapsulation and Transplantation into Diabetic Mice of Human Induced Pluripotent Stem Cells (hiPSC)-Derived Pancreatic Progenitors. - Highly Efficient Differentiation of Human Pluripotent Stem Cells into Pancreatic Progenitors Co-expressing PDX1 and NKX6.1. - Derivation of Three-Dimensional Human Induced Pluripotent Stem Cell-Derived Vocal Fold Mucosa for Clinical and Pharmacological Applications. - Generation of Human Induced Pluripotent Stem Cells Using Endothelial Progenitor Cells Derived from Umbilical Cord Blood and Adult Peripheral Blood. - Development of a Blood-Brain Barrier Permeability Assay Using Human Induced Pluripotent Stem Cell Derived Brain Endothelial Cells. - Revised "hPSC-Sac Method" for Simple and Efficient Differentiation of Human Pluripotent Stem Cells to Hematopoietic Progenitor Cells. - Efficient Generation of iPSC-Derived Hematoendothelial Progenitors and Specification Toward T cell Lineage. - Derivation and Characterization of Mesenchymal Stem Cells from iPS Cells. - Human Pluripotent Stem Cell Differentiation to Microglia. - Human Induced Pluripotent Stem Cell-Derived Microglia (hiPSC-Microglia). - Isolation and Culture of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoid Cells. - A Simple Method for Generating, Clearing, and Imaging Pre-vascularized 3D Adipospheres Derived from Human iPS Cells. - A Method for In Vitro Fabrication of Hybrid Bone/Cartilage Tissue Using Mouse Induced Pluripotent Stem Cells. - Differentiation of Human Induced Pluripotent Stem Cells (hiPSC) into Endothelial-Type Cells and Establishment of an In Vitro Blood-Brain Barrier Model. - CRISPR/Cas9-Mediated Introduction of Specific Heterozygous Mutations in Human Induced Pluripotent Stem Cells. - CRISPR/Cas9-Mediated Gene Knockout and Knockin Human iPSCs. - Generation of Monoclonal iPSC Lines with Stable Cas9 Expression and High Cas9 Activity. - CRISPR/Cas9-Mediated Genome Editing to Generate Clonal iPSC Lines. - CRISPR/Cas9 Ribonucleoprotein Complex-Mediated Efficient B2M Knockout in Human Induced Pluripotent Stem Cells (iPSCs). - Embryonal Carcinoma and Glioblastoma Cell Lines Derived from Monkey Induced Pluripotent Stem Cells. - Methods for Isolation and Reprogramming of Various Somatic Cell Sources into iPSCs. - The Characteristics of Human iPS Cells and siRNA Transfection Under Hypoxia. - mRNA-Based Reprogramming Under Xeno-Free and Feeder-Free Conditions. - Non-modified RNA-Based Reprogramming of Human Dermal Fibroblasts into Induced Pluripotent Stem Cells. - Efficient Induction of Primate iPS Cells Using a Combination of RNA Transfection and Chemical Compounds. - Generation and Cultivation of Transgene-Free Macaque and Baboon iPSCs Under Chemically Defined Conditions. - Generation of Marmoset Monkey iPSCs with Self-Replicating VEE-mRNAs in Feeder-Free Conditions. - Differentiation of Human Induced Pluripotent Stem Cells into Definitive Endoderm Using Simple Dialysis Culture Device. - Detecting and Modulating ER Stress to Improve Generation of Induced Pluripotent Stem Cells. - Gene Editing in Human Induced Pluripotent Stem Cells Using Doxycycline-Inducible CRISPR-Cas9 System. - Derivation of Clinical-Grade Induced Pluripotent Stem Cell Lines from Erythroid Progenitor Cells in Xenofree Conditions. - Generation of Murine Induced Pluripotent Stem Cells through Transposon-Mediated Reprogramming. - Human Pluripotent Stem Cells for High-Throughput Drug Screening and Characterization of Small Molecules. - Correction to: Human Pluripotent Stem Cells for High-Throughput Drug Screening and Characterization of Small Molecules.